Effectiveness Of Mobile Application To Improve Adherence To Tuberculosis Treatment
NCT05259254 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 300
Last updated 2022-11-07
Summary
Tuberculosis (TB) is a major public health concern, where it is among the top ten causes of death and the leading cause of death due to a single infectious agent globally. Providing standard anti-TB therapy for at least six months is recommended as one of the important strategies to control TB epidemic. However, prolonged duration of TB treatment raised issues of non-adherence. Non-adherence to TB therapy could negatively affect clinical and public health outcomes. Introduction of Direct Observed Therapy (DOT) has been used as a standard strategy to improve anti-TB adherence. Nonetheless, the DOT approach has been criticized due to inconvenience, stigma, reduced economic productivity, and reduced quality of life which ultimately could complicate the adherence issues. Apart from that, its effectiveness is debatable. Therefore, digital adherence technology could be an important alternative to DOT. Incorporation of Health Belief Model into the development of digital technology could potentially help to change behaviour and improve medication adherence. Hence, this study aimed to determine the effectiveness, feasibility, and usability of mobile application in improving TB medication adherence. This study proposed to conduct a pilot study to assess feasibility and usability followed by randomized, open-label, control trial among TB patients receiving TB care in several public health clinics in Kota Kinabalu, Putatan, and Penampang, Sabah, Malaysia. The eligible sample will be randomly assigned into mobile application DOT arm (intervention arm) and standard DOT arm (control arm). The primary outcome for this study is the successful completion of 80% or more of treatment observations that was scheduled in the two months following randomization. The secondary outcome measures are continuous variables including health related quality of life (HR-QOL), satisfaction level, and employment status. Multiple logistic regression analysis will be used to determine factors associated with primary outcome. Intention to treat and restricted analysis will be conducted. Independent sample t-test and repeated measures ANOVA will be used to compare the continuous secondary outcome between two intervention arms. The findings from this study are hopefully could provide insight into rethinking TB care delivery in order to achieve better TB treatment outcome.
Conditions
Interventions
- OTHER
-
Mobile Application
the mobile application will be consist of 4 modules which are: video observed therapy, health education, reminder system, and feedback.
- OTHER
-
Direct Observed Therapy
it is a specific strategy that require identification, training, and supervision by various parties such as healthcare worker, community volunteer, or family members to directly monitor the ingestion of anti-TB medication. DOT was aimed to improve medication adherence by active monitoring and documenting the consumption of each dose taken. Conducting DOT is not only limited to directly observe the treatment, but also can assess medication side effects as well as to document the visit and information regarding medications (e.g., frequency and timing of taking medication).
Sponsors & Collaborators
-
Ministry of Health, Malaysia
collaborator OTHER_GOV -
Mohd Fazeli bin Sazali
lead OTHER
Principal Investigators
-
Mohd Fazeli bin Sazali, MD, MPH · Universiti Malaysia Sabah
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-06-01
- Primary Completion
- 2023-05-28
- Completion
- 2023-05-28
Countries
- Malaysia
Study Locations
More Related Trials
-
Intervention in the Management of Post-high Tuberculosis Hospital Through Educational Strategy and Oversight Distance
NCT02558842 ·Status: COMPLETED ·Phase: NA
-
Promoting Adherence to Treatment for Latent TB Infection Through Text Messaging
NCT02690818 ·Status: COMPLETED ·Phase: NA
-
Fermented Soybean Supplementation Among Active Pulmonary Tuberculosis Patients With Standard Therapy in Indonesia
NCT02554318 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Safety Study of Immunomodulator as an Adjunct Therapy in Pulmonary Tuberculosis (TB) Retreatment Patients
NCT00265226 ·Status: COMPLETED ·Phase: PHASE3
-
Choice Architecture Based TB Preventive Therapy Prescribing
NCT04466293 ·Status: COMPLETED ·Phase: NA
-
Promoting Overall Care and Management Related to Tuberculosis Infection Through Pharmaceutical Care and Text Messaging
NCT04264221 ·Status: UNKNOWN ·Phase: NA
-
Using SMS Reminders, Phone Calls and Money Incentives to Enhance Linkage to Care of Presumptive TB Patients in Uganda
NCT05964842 ·Status: COMPLETED ·Phase: NA
-
A Multiple Ascending Dose Study With a Dose Formulation Comparison Cohort to Evaluate the Safety, Tolerability, and Pharmacokinetics of TBA-354 in Healthy Adult Subjects
NCT02606214 ·Status: TERMINATED ·Phase: PHASE1
-
A Phase 1 Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of TBA-354 in Healthy Adult Subjects
NCT02288481 ·Status: COMPLETED ·Phase: PHASE1
-
TB mHealth Study - Use of Cell Phones to Improve Compliance in Patients on LTBI Treatment
NCT01549457 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Optimizing(O) RIfapentine-based(RI) Regimen and shortENing(EN) the Treatment of Drug-sensitive Tuberculosis(T)
NCT05401071 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
Study on the Management Model of "Home Treatment" for Tuberculosis Patients
NCT03967353 ·Status: UNKNOWN ·Phase: NA
-
Immunogenicity of COVID-19 Vaccines in Tuberculosis Patients
NCT05571735 ·Status: RECRUITING
-
TB YOUTH - TB sYstemic Management Using One-month, Ultra-short TPT Regimen for scHool Contacts
NCT06022146 ·Status: RECRUITING ·Phase: PHASE3
-
Mobile Health Intervention for Active Tuberculosis
NCT03544476 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Three Regimens of Chemoprophylaxis for Tuberculosis in Patients co-Infected by HIV and Mycobacterium Tuberculosis
NCT00402454 ·Status: COMPLETED ·Phase: PHASE4
-
Food Incentives for TB Treatment Compliance in East Timor (FITTCET)
NCT00192556 ·Status: COMPLETED ·Phase: NA
-
The Impact of Malnutrition on Immune Responses to Tuberculosis
NCT05044910 ·Status: ACTIVE_NOT_RECRUITING
-
The Effect of 18-month Regimen Containing 6 Anti-tuberculosis Drugs for Patients With MDR-TB
NCT03830671 ·Status: COMPLETED ·Phase: PHASE4
-
Safety and Effectiveness of Delamanid-containing Regimen for MDR-TB Patients in China
NCT04421495 ·Status: UNKNOWN ·Phase: PHASE4
-
Effectiveness of the TB Contact Priority Model
NCT00149448 ·Status: COMPLETED
-
Training Lay Healthcare Workers to Optimize TB Care and Improve Outcomes in Malawi
NCT02533089 ·Status: COMPLETED ·Phase: NA
-
Real-time Tuberculosis Medication Adherence Intervention in Rural Southwestern Uganda
NCT03800888 ·Status: UNKNOWN ·Phase: NA
-
Assessing Diagnostics At Point-of-care for Tuberculosis
NCT05941052 ·Status: RECRUITING ·Phase: NA
-
The Incidence and Risk Factors of Side Effects During the Initial Phase of Rifater Therapy - a Prospective Study
NCT01182259 ·Status: UNKNOWN